Planned neck dissection following chemo-radiotherapy in advanced HNSCC

International Seminars in Surgical Oncology

Volumn 1, Issue , 2004, Pages

  Gupta, Tejpal ^a   Agarwal, Jai Prakash ^b  

^a Research Centre   (India)

^b TATA MEMORIAL HOSPITAL   (India)

Author keywords

Chemo radiotherapy; HNSCC; Neck dissection

Indexed keywords

ANTINEOPLASTIC AGENT;

ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL TRIAL; EMBASE; EVIDENCE BASED MEDICINE; HEAD AND NECK CARCINOMA; HUMAN; MEDLINE; MULTIMODALITY CANCER THERAPY; NECK DISSECTION; REVIEW; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 18144365493     PISSN: 14777800     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-7800-1-6     Document Type: Review

References (26)

1. Garg M, Beitler JJ: Controversies in Management of the Neck in Head and Neck Cancer. Curr Treat Options Oncol 2004, 5:35-40.
2. McHam SA, Adelstein DJ, Rybicki LA, Lavertu P, Esclamado RM, Wood BG, Strome M, Carroll MA: Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer. Head Neck 2003, 25:791-798.
3. Parsons JT, Mendenhall WM, Cassisi NJ, Stringer SP, Million RR: Neckdissection after twice-a-day radiotherapy: Morbidity and recurrence rates. Head Neck 1989, 11:400-404.
4. Mendenhall WM, Villaret DB, Amdur RJ, Hinerman RW, Mancuso AA: Planned neck dissection after definitive radiotherapy for squamous cell carcinoma ofthe head and neck. Head Neck 2002, 24: 1012-1018.
5. Pignon JP, Bourhis J, Domenge C, Designe L: Chemotherapy added to loco-regional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data (for the Meta-Analysis of Chemotherapy on Head and Neck Cancer (MACH-NC) Collaborative group. Lancet 2000, 355:949-955.
6. Browman GP, Hodson DI, Mackenzie RJ, Bestic N, Zuraw L, Cancer Care Ontario Practice Guideline Initiative Head and Neck Cancer Disease Site Group: Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis. Head Neck 2001, 23:579-589.
7. Grabenbauer GG, Rodel C, Ernst-Stecken A, Brunner T, Hornung J, Kittel K, Steinhart H, Iro H, Sauer R, Schultze-Mosgau S: Neck dissection following radiochemotherapy of advanced head and neck cancer-for selected cases only? Radiother Oncol 2003, 66:57-63.
8. Corry J, Smith JG, Peters LJ: The concept of a planned neck dissection is obsolete. Cancer J 2001, 7:472-474.
9. American Society of Clinical Oncology (ASCO): Clinical practice guidelines for the use of chemotherapy and radiotherapy protectants. J Clin Oncol 1999, 17:3333-3355.
10. Carinci F, Cassano L, Farina A, Pelucchi S, Calearo C, Modugno V, Nielsen I, Api P, Pastore A: Unresectable primary tumor of head and neck: does neck dissection combined with chemoradiotherapy improve survival. J Craniofac Surg 2001, 12:438-443.
11. Argiris A, Stenson KM, Brockstein BE, Mittal BB, Pelzer H, Kies MS, Jayaram P, Portugal L, Weing BL, Rosen FR, Haraf DJ, Vokes EE: Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck 2004, 26:447-455.
12. Brizel DM, Prosnitz RG, Hunter S, Fisher SR, Clough RL, Downey MA, Scher RL: Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004, 58:1418-1423.
13. Clayman GL, Johnson CJ II, Morrison W, Ginsberg L, Lippman SM: The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal disease. Arch Otolaryngol Head Neck Surg 2001, 127:135-139.
14. Stenson KM, Haraf DJ, Pelzer H, Recant W, Kies MS, Weichselbaum RR, Vokes EE: The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: The feasibility of selective neck dissection. Arch Otolaryngol Head Neck Surg 2000, 126:950-956.
15. Robbins KT, Wong FSH, Kumar P, Hartsell WF, Vieira F, Mullins B, Barry Niell H: Efficacy of targeted chemoradiation and planned selective neckdissection to control bulky nodal disease in advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 1999, 125:670-675.
16. Lavertu P, Adelstein DJ, Saxton JP, Sesic M, Eliachar I, Strome M, Larto MA, Wood BG: Aggressive concurrent chemo-radiotherapy for squamous cell head and neck cancer: An 8-year single-institution experience. Arch Otolaryngol Head Neck Surg 1999, 125: 142-148.
17. Lavertu P, Adelstein DJ, Saxton JP, Secic M, Wanamaker JR, Eliachar I, Wood BG, Strome M: Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer. Head Neck 1997, 19:559-566.
18. Wanebo H, Chougule P, Ready N, Safran H, Ackerley W, Koness RJ, McRae R, Nigri P, Leone L, Radie-Keane K, Reiss P, Kennedy T: Surgical resection is necessary to maximize tumor control in function-preserving, aggressive chemoradiation protocols for advanced squamous cancer of the head and neck (stage III and IV). Ann Surg Oncol 2001, 8:644-650.
19. Newkirk KA, Cullen KJ, William Harter K, Picken CA, Sessions RB, Davidson BJ: Planned neck dissection for advanced primary head and neckmalignancy treated with organ preservation therapy: disease control and survival outcomes. Head Neck 2001, 23:73-79.
20. Ahmed KA, Robbins KT, Wong F, Salazar JE: Efficacy of concomitant chemoradiation and surgical salvage for N3 nodal disease associated with upper aero-digestive tract carcinoma. Laryngoscope 2000, 110:1789-1793.
21. Sanguineti G, Corvo R, Benasso M, Margarino G, Sormani MP, Roncallo F, Mereu P, Bacigalupo A, Vitale V: Management of the neck after alternating chemoradiotherapy for advanced head and neck cancer. Head Neck 1999, 21:223-228.
22. Weisman RA, Christen RD, Jones VE, Kerber CW, Seagren SL, Orloff LA, Glassmeyer SL, Howell SB, Robbins KT: Observations on control of N2 and N3 neck disease in squamous cell carcinoma of the head and neck by intra-arterial chemoradiation. Laryngoscope 1998, 108:800-805.
23. Dagum P, Pinto HA, Newman JP, Higgins JP, Terris DJ, Goffinet DR, Fee WE Jr: Management of the clinically positive neck in organ preservation for advanced head and neck cancer. Am J Surg 1998, 176:448-452.
24. Koch WM, Lee DJ, Eisele DW, Miller D, Poole M, Cummings CW, Forastiere AA: Chemo-radiotherapy for organ preservation in oral and pharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 1995, 121:974-980.
25. Narayan K, Crane CH, Kleid S, Hughes PG, Peters LJ: Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy: For some or for all? Head Neck 1999, 21:606-613.
26. Strasser MD, Gleich LL, Miller MA, Saavedra HI, Gluckman JL: Management implications of evaluating the N2 and N3 neck after organ preservation therapy. Laryngoscope 1999, 109:1776-1780.